Concepedia

Kevin J. Merchant

KJ

Statistics

Publications

23

Citations

1.5K

H-Index

19

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

United States Military Academy

Kevin J. Merchant is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and medicine.

ORCID

Publications per year

1988–2021

23

Publications

23

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

F.D. Tattersall, Wayne Rycroft, B. Francis et al. · Neuropharmacology · 1996 · 211 citations

, , +4

Novel quinuclidine-based ligands for the muscarinic cholinergic receptor

John Saunders, Stephen B. Freedman, Elizabeth A. Harley et al. · Journal of Medicinal Chemistry · 1990 · 158 citations

, , +17

Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines

Frank Wätjen, R. BAKER, Mogens Engelstoff et al. · Journal of Medicinal Chemistry · 1989 · 133 citations

, , +6

Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors

R. BAKER, T. BOOK, Clare O. Kneen et al. · Journal of Medicinal Chemistry · 1990 · 133 citations

, , +17

8-Fluoroimidazo[1,2-a]pyridine: Synthesis, physicochemical properties and evaluation as a bioisosteric replacement for imidazo[1,2-a]pyrimidine in an allosteric modulator ligand of the GABAA receptor

Alexander C. Humphries, Emanuela Gancia, Myra T. Gilligan et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 115 citations · Full text

, , +17

1–5 of 23